🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Invion Ltd (IVX)

Sydney
Currency in AUD
Disclaimer
0.004
+0.001(+0.00%)
Closed
IVX Scorecard
Full Analysis
Significant return over the last week
Fair Value
Day's Range
0.0030.004
52 wk Range
0.0020.008
Bid/Ask
0.003 / 0.004
Prev. Close
0.003
Open
0.003
Day's Range
0.003-0.004
52 wk Range
0.002-0.008
Volume
3,200,201
Average Volume (3m)
4,287,389
1-Year Change
-40%
Fair Value
Unlock
Fair Value Upside
Unlock
IVX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility
  • Inventronics Announces 2024 Q2 Financial Results
    • Investing.com
  • Inventronics Declares Special Dividend
    • Investing.com
  • Inventronics Announces 2024 Q1 Financial Results
    • Investing.com
Show more

Invion Ltd Company Profile

Invion Limited, a clinical-stage life-sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, and solid cancers, such as lung, ovarian, anogenital, and glioblastoma multiforme cancers. It has a research and development agreement with Hudson Institute of Medical Research to develop a novel photosensitiser for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion’s IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. Invion Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.

Compare IVX to Peers and Sector

Metrics to compare
IVX
Peers
Sector
Relationship
P/E Ratio
−4.8x−3.0x−0.6x
PEG Ratio
0.020.000.00
Price/Book
1.9x2.1x2.6x
Price / LTM Sales
7.3x4.3x3.2x
Upside (Analyst Target)
516.7%115.4%48.4%
Fair Value Upside
Unlock16.9%6.8%Unlock

FAQ

What Is the Invion Ltd (IVX) Stock Price Today?

The Invion Ltd stock price today is 0.004

What Stock Exchange Does Invion Ltd Trade On?

Invion Ltd is listed and trades on the Sydney stock exchange.

What Is the Stock Symbol for Invion Ltd?

The stock symbol for Invion Ltd is "IVX."

What Is the Invion Ltd Market Cap?

As of today, Invion Ltd market cap is 27.07M.

What is Invion Ltd Earnings Per Share?

The Invion Ltd EPS is -0.001.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.